Healthcare - Biotechnology - NASDAQ - US
$ 1.61
0.625 %
$ 83.3 M
Market Cap
-1.61
P/E
Price Target
Average
929.28%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
24.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
PMV Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for PMVP of $16.6 , with forecasts ranging from a low of $5 to a high of $36 .
PMVP Lowest Price Target
Wall Street Target
5 USD
210.56%
PMVP Average Price Target
Wall Street Target
16.6 USD
929.28%
PMVP Highest Price Target
Wall Street Target
36 USD
2136.02%
REVENUE FORECAST
Revenue Forecast Chart PMVP
EBIT FORECAST
EBIT Forecast Chart PMVP
NET INCOME FORECAST
Net Income Chart PMVP